Nationwide Fund Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-95,229
| Closed | -$323K | – | 3093 |
|
|
2017
Q3 | $323K | Sell |
95,229
-14,732
| -13% | -$50K | ﹤0.01% | 2401 |
|
|
2017
Q2 | $272K | Buy |
109,961
+4,900
| +5% | +$12.1K | ﹤0.01% | 2495 |
|
|
2017
Q1 | $238K | Sell |
105,061
-5,429
| -5% | -$12.3K | ﹤0.01% | 2509 |
|
|
2016
Q4 | $234K | Buy |
110,490
+1,537
| +1% | +$3.26K | ﹤0.01% | 2531 |
|
|
2016
Q3 | $365K | Hold |
108,953
| – | – | ﹤0.01% | 2329 |
|
|
2016
Q2 | $342K | Buy |
108,953
+2,713
| +3% | +$8.52K | ﹤0.01% | 2352 |
|
|
2016
Q1 | $354K | Sell |
106,240
-3,300
| -3% | -$11K | ﹤0.01% | 2272 |
|
|
2015
Q4 | $388K | Sell |
109,540
-174,293
| -61% | -$617K | ﹤0.01% | 2245 |
|
|
2015
Q3 | $1.43M | Buy |
283,833
+34,300
| +14% | +$173K | 0.01% | 1544 |
|
|
2015
Q2 | $1.6M | Sell |
249,533
-11,315
| -4% | -$72.7K | 0.01% | 1570 |
|
|
2015
Q1 | $1.84M | Sell |
260,848
-5,016
| -2% | -$35.3K | 0.01% | 1537 |
|
|
2014
Q4 | $2.05M | Sell |
265,864
-1,378
| -0.5% | -$10.6K | 0.01% | 1397 |
|
|
2014
Q3 | $2M | Buy |
267,242
+6,776
| +3% | +$50.6K | 0.01% | 1439 |
|
|
2014
Q2 | $2.52M | Sell |
260,466
-27,152
| -9% | -$263K | 0.01% | 1353 |
|
|
2014
Q1 | $2.39M | Buy |
287,618
+178,861
| +164% | +$1.49M | 0.01% | 1255 |
|
|
2013
Q4 | $918K | Sell |
108,757
-3,063
| -3% | -$25.9K | ﹤0.01% | 1920 |
|
|
2013
Q3 | $891K | Buy |
111,820
+5,359
| +5% | +$42.7K | ﹤0.01% | 1897 |
|
|
2013
Q2 | $822K | Buy |
+106,461
| New | +$822K | ﹤0.01% | 1770 |
|